James T. Borello
NBIX icon

James T. Borello’s Neurocrine Biosciences NBIX Stock Holding History

James T. Borello’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15K Buy
106
+2
+2% +$321 ﹤0.01% 497
2026
Q2 		$17.5K Buy
+104
New +$15.4K ﹤0.01% 449
2026
Q1 		– Sell
-30
Closed -$4.26K – 1233
2025
Q4 		$4.26K Buy
30
+18
+150% +$2.61K ﹤0.01% 609
2025
Q3 		$1.68K Buy
+12
New +$1.63K ﹤0.01% 752

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seizert Capital Partners
Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
PKO BP Bankowy Universal Pension Society
PKO BP Bankowy Universal Pension Society Warsaw, Poland $340M AUM 228.33% 1-Year Est. Return
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

James T. Borello's NBIX Position: Q3 2026 in Review

James T. Borello increased its Neurocrine Biosciences (NBIX) stake by 1.9% in Q3 2026, buying an estimated $321 and bringing the position to 106 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

James T. Borello first reported a position in NBIX in Q3 2025 and has held it in 4 quarters since. The position peaked at $17.5K in Q2 2026. 238 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • James T. Borello held 106 shares of Neurocrine Biosciences worth $15K as of Q3 2026.
  • James T. Borello bought 2 Neurocrine Biosciences shares in Q3 2026, an estimated $321.
  • Neurocrine Biosciences made up ﹤0.01% of James T. Borello's portfolio in Q3 2026, its #497 holding.
  • James T. Borello first reported a position in Neurocrine Biosciences in Q3 2025 and has held it in 4 quarters since.
  • James T. Borello's Neurocrine Biosciences position peaked at $17.5K in Q2 2026.
  • 238 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.